Back
Virtus LifeSci Biotech Clinical Trls ETF Vs. United States Cellular Industry Stock Comparison
Buy
69
BBC
Virtus LifeSci Biotech Clinical Trls ETF
Last Price:
27.26
Seasonality Move:
6.6%
Buy
71
USM
United States Cellular
Last Price:
44.44
Seasonality Move:
5.31%
Buy
69
Virtus LifeSci Biotech Clinical Trls ETF (BBC)
is a Buy
Is Virtus LifeSci Biotech Clinical Trls ETF a Buy, Sell or Hold?
- The current Virtus LifeSci Biotech Clinical Trls ETF [BBC] share price is $27.26. The Score for BBC is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- BBC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
United States Cellular (USM)
is a Buy
Is United States Cellular a Buy, Sell or Hold?
- The current United States Cellular [USM] share price is $45.10. The Score for USM is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- USM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BBC Stock Price Chart
What is Virtus LifeSci Biotech Clinical Trls ETF's stock price today?
-
The Virtus LifeSci Biotech Clinical Trls ETF share price today is $27.26
The current trend is moderately bullish and BBC is experiencing selling pressure, which indicates risk of future bearish movement.
USM Stock Price Chart
What is United States Cellular's stock price today?
-
The United States Cellular share price today is $45.10
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and USM is experiencing buying pressure, which is a positive indicator for future bullish movement.
BBC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 50.89 | Buy |
| Chaikin Money Flow: | -3187 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.52 - 27.62) | Buy |
| Bollinger Bands (100): | (25.2 - 29.02) | Buy |
USM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.46 | Buy |
| Relative Strength Index (14 RSI): | 67.73 | Buy |
| Chaikin Money Flow: | 133355 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.95 - 42.71) | Buy |
| Bollinger Bands (100): | (34.57 - 42.69) | Buy |
BBC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.35 | Sell |
| 20-day SMA: | 26.79 | Buy |
| 50-day SMA: | 27.54 | Sell |
| 200-day SMA: | 23.65 | Buy |
| 8-day EMA: | 27.4 | Sell |
| 20-day EMA: | 27.16 | Buy |
| 50-day EMA: | 27.15 | Buy |
| 200-day EMA: | 25.27 | Buy |
USM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.04 | Buy |
| 20-day SMA: | 39.26 | Buy |
| 50-day SMA: | 37.06 | Buy |
| 200-day SMA: | 40.1 | Buy |
| 8-day EMA: | 43.38 | Buy |
| 20-day EMA: | 40.49 | Buy |
| 50-day EMA: | 38.49 | Buy |
| 200-day EMA: | 36.73 | Buy |
Virtus LifeSci Biotech Clinical Trls ETF Earnings Growth & BBC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
United States Cellular Earnings Growth & USM Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.84 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.75 per share, and a decrease next year of $3.46 per share.
Virtus LifeSci Biotech Clinical Trls ETF Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
United States Cellular Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||